TLR7 ligands can not only activate directly NK cells and cytotoxic T-cells [45,46], but also hamper the suppressive function of myeloid-derived suppressor cells [47,48] and interfere with the migration of Tregs into the tumour [49]. Here, TLR7 is linked to neoplasm.